chr1-196673839-C-CTTT
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000186.4(CFH):c.245-11_245-9dupTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00252 in 1,479,616 control chromosomes in the GnomAD database, including 15 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0016 ( 7 hom., cov: 23)
Exomes 𝑓: 0.0026 ( 8 hom. )
Consequence
CFH
NM_000186.4 splice_region, intron
NM_000186.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0950
Genes affected
CFH (HGNC:4883): (complement factor H) This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-196673839-C-CTTT is Benign according to our data. Variant chr1-196673839-C-CTTT is described in ClinVar as [Likely_benign]. Clinvar id is 1168607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00159 (240/151262) while in subpopulation AMR AF= 0.0131 (199/15190). AF 95% confidence interval is 0.0116. There are 7 homozygotes in gnomad4. There are 125 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFH | NM_000186.4 | c.245-11_245-9dupTTT | splice_region_variant, intron_variant | ENST00000367429.9 | NP_000177.2 | |||
CFH | NM_001014975.3 | c.245-11_245-9dupTTT | splice_region_variant, intron_variant | NP_001014975.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFH | ENST00000367429.9 | c.245-11_245-9dupTTT | splice_region_variant, intron_variant | 1 | NM_000186.4 | ENSP00000356399.4 | ||||
ENSG00000289697 | ENST00000696032.1 | c.245-11_245-9dupTTT | splice_region_variant, intron_variant | ENSP00000512341.1 |
Frequencies
GnomAD3 genomes AF: 0.00158 AC: 239AN: 151148Hom.: 7 Cov.: 23
GnomAD3 genomes
AF:
AC:
239
AN:
151148
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00262 AC: 3483AN: 1328354Hom.: 8 Cov.: 25 AF XY: 0.00231 AC XY: 1542AN XY: 666934
GnomAD4 exome
AF:
AC:
3483
AN:
1328354
Hom.:
Cov.:
25
AF XY:
AC XY:
1542
AN XY:
666934
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00159 AC: 240AN: 151262Hom.: 7 Cov.: 23 AF XY: 0.00169 AC XY: 125AN XY: 73824
GnomAD4 genome
AF:
AC:
240
AN:
151262
Hom.:
Cov.:
23
AF XY:
AC XY:
125
AN XY:
73824
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Factor H deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Hemolytic uremic syndrome, atypical, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Basal laminar drusen Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Age related macular degeneration 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Atypical hemolytic-uremic syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Dec 30, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at